Next report date
Report period
Q4 2023
EPS estimate
—
Revenue estimate
145.62 MEUR
0.5EUR
46.18 MEUR
717.14 MEUR
16.49 M
About MOCHIDA PHARM.
Sector
Headquarters
Tokyo
Employees (FY)
1.53 K
Website
Founded
1913
ISIN
JP3922800002
FIGI
BBG000C4SM44
Mochida Pharmaceutical Co. Ltd. engages in the research, development, manufacturing and sale of pharmaceuticals, healthcare products, and medical equipment. It operates through following business divisions: Pharmaceuticals and Healthcare Products. The Pharmaceuticals division conducts research and development for medical needs. The Healthcare Products division manufactures and sells cosmetic and medicated products. It also manufactures and sells prescription drugs for cardiovascular, obstetrics and gynecology, dermatology, emergency and psychiatric ailments. The company was founded by Ryokichi Mochida in February 1913 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MOCHIDA PHARM. stocks are traded under the ticker MFY.
MOCHIDA PHARM. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
MOCHIDA PHARM. revenue for the last quarter amounts to 156.55 M EUR despite the estimated figure of 158.60 M EUR. In the next quarter revenue is expected to reach 178.66 M EUR.
Yes, you can track MOCHIDA PHARM. financials in yearly and quarterly reports right on TradingView.
MFY net income for the last quarter is 10.31 M EUR, while the quarter before that showed 7.28 M EUR of net income which accounts for 41.64% change. Track more MOCHIDA PHARM. financial stats to get the full picture.
MOCHIDA PHARM. dividend yield was 2.40% in 2022, and payout ratio reached 44.71%. The year before the numbers were 2.41% and 32.45% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MFY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOCHIDA PHARM. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 1.53 K employees. See our rating of the largest employees — is MOCHIDA PHARM. on this list?
We've gathered analysts' opinions on MOCHIDA PHARM. future price: according to them, MFY price has a max estimate of 19.42 EUR and a min estimate of 19.42 EUR. Read a more detailed MOCHIDA PHARM. forecast: see what analysts think of MOCHIDA PHARM. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOCHIDA PHARM. EBITDA is 43.01 M EUR, and current EBITDA margin is 10.83%. See more stats in MOCHIDA PHARM. financial statements.